Analysis of Antiangiogenic Potential and Cell Death Mechanism of a Kinetically Inert Platinum Antitumor Agent
- 19 August 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 15 (9) , 1482-1490
Abstract
Cancer is a multifaceted disease involving various pathological processes, including uncontrolled proliferation, development of resistance, angiogenesis, metastasis, etc. Therefore, chemotherapeutic agents capable of simultaneously inhibiting proliferation, circumventing chemoresistance, and inhibiting angiogenesis can address multiple aspects of cancer progression. We recently identified a highly promising kinetically inert platinum antitumor agent, namely, Pt-1, that can circumvent cisplatin resistance and showed negligible nephrotoxicity. In this study, we explored the antiangiogenic potential and elucidated the detailed mechanism of cell death through which it exerts its antitumor activity. Pt-1 strongly inhibited angiogenesis in a zebrafish in vivo model at its therapeutically relevant nontoxic dose. Further, Pt-1 exerted antitumor activity through necroptosis- and paraptosis-mediated cell death. Taken together, the combination of antitumor activity with antiangiogenic property in Pt-1 makes it a highly promising antitumor candidate.Keywords
Funding Information
- Department of Atomic Energy, Government of India (RTI4003)
- Tata Institute of Fundamental Research
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR26241/GET/119/244/2017)
This publication has 38 references indexed in Scilit:
- The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating NephrotoxicityAngewandte Chemie International Edition, 2023
- Potent Ruthenium–Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in ZebrafishJournal of Medicinal Chemistry, 2022
- A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exertsin VivoEfficacyChemistry – A European Journal, 2022
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A reviewJournal of Advanced Research, 2017
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsChemical Reviews, 2016
- Patterning mechanisms of the sub-intestinal venous plexus in zebrafishDevelopmental Biology, 2016
- Poly(ADP-ribose): A signaling molecule in different paradigms of cell deathBiochemical Pharmacology, 2014
- TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell deathCellular and Molecular Life Sciences, 2013
- The role of angiogenesis in solid tumours: An overviewEuropean Journal of Internal Medicine, 2009
- The Vascular Anatomy of the Developing Zebrafish: An Atlas of Embryonic and Early Larval DevelopmentDevelopmental Biology, 2001